Prophylaxis of Reperfusion Complications in Treatment of Acute Myocardial Infarction in Type 2 Diabetes Mellitus Patients
Purpose — to identify the possibility of improving the outcome of multimodality treatment of acute myocardial infarction (AMI) in type 2 diabetes mellitus (DM) patients by use of a succinate-containing drug.Materials and methods. The results of examination and treatment of 86 men aged 40 to 70 years...
Saved in:
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology, Moscow, Russia
2019-07-01
|
| Series: | Общая реаниматология |
| Subjects: | |
| Online Access: | https://www.reanimatology.com/rmt/article/view/1771 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850029250353037312 |
|---|---|
| author | E. A. Kornienko |
| author_facet | E. A. Kornienko |
| author_sort | E. A. Kornienko |
| collection | DOAJ |
| description | Purpose — to identify the possibility of improving the outcome of multimodality treatment of acute myocardial infarction (AMI) in type 2 diabetes mellitus (DM) patients by use of a succinate-containing drug.Materials and methods. The results of examination and treatment of 86 men aged 40 to 70 years with clinical diagnosis of AMI and concomitant type 2 DM were analyzed. The patients were split into two groups depending on use of the succinate-containing drug. Patients of the control group (38 men, 58.3±7.1 years old) received the standard treatment that included percutaneous coronary intervention (PCI). In the main group under study (48 men, 57.6±7.6 years old), the standard therapy complex was complemented with administration of a succinate-containing drug (1.5% succinic acid solution), which was administered first 30–60 minutes prior to PCI intravenously at a dose of 10–12 ml/kg; then, daily once a day, for 5 days at a dose of 5–6 ml/kg. Peculiarities of the AMI clinical course, dynamics of myocardial contractility, values of acid-base balance (ABB), glucose and lactate content, lipid peroxidation (LPO) and antioxidant system (AOS), rheological properties of the blood were evaluated.Results. During AMI type 2 DM patients developed compensated metabolic lactic acidosis and oxidative distress that manifested in considerable activation of LPO and insufficient activity of the enzymatic component of AOS, blood viscosity grew, elasticity of red blood cells fell. Decreased local and global myocardial contractility was noted as well. During PCI in this category of patients, cardiac rhythm disorders developed in 47.4% of cases, 23.7% of which were life threatening, such as multifocal ventricular extra systole and ventricular fibrillation. Conclusion. Administration of a succinate-containing drug during performance of PCI provided correction of the lipid peroxidation processes and rheological properties of the blood in the population studied, facilitated improvement of left ventricle’s systolic and diastolic function, reduced the risk of reperfusion complications. |
| format | Article |
| id | doaj-art-a1b2653379444abfa6586ef7bd6e5f02 |
| institution | DOAJ |
| issn | 1813-9779 2411-7110 |
| language | English |
| publishDate | 2019-07-01 |
| publisher | Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology, Moscow, Russia |
| record_format | Article |
| series | Общая реаниматология |
| spelling | doaj-art-a1b2653379444abfa6586ef7bd6e5f022025-08-20T02:59:34ZengFederal Research and Clinical Center of Intensive Care Medicine and Rehabilitology, Moscow, RussiaОбщая реаниматология1813-97792411-71102019-07-0115341810.15360/1813-9779-2019-3-4-181686Prophylaxis of Reperfusion Complications in Treatment of Acute Myocardial Infarction in Type 2 Diabetes Mellitus PatientsE. A. Kornienko0A. A. Vishnevsky 3d Central Military Clinical Hospital, Ministry of Defense of RussiaPurpose — to identify the possibility of improving the outcome of multimodality treatment of acute myocardial infarction (AMI) in type 2 diabetes mellitus (DM) patients by use of a succinate-containing drug.Materials and methods. The results of examination and treatment of 86 men aged 40 to 70 years with clinical diagnosis of AMI and concomitant type 2 DM were analyzed. The patients were split into two groups depending on use of the succinate-containing drug. Patients of the control group (38 men, 58.3±7.1 years old) received the standard treatment that included percutaneous coronary intervention (PCI). In the main group under study (48 men, 57.6±7.6 years old), the standard therapy complex was complemented with administration of a succinate-containing drug (1.5% succinic acid solution), which was administered first 30–60 minutes prior to PCI intravenously at a dose of 10–12 ml/kg; then, daily once a day, for 5 days at a dose of 5–6 ml/kg. Peculiarities of the AMI clinical course, dynamics of myocardial contractility, values of acid-base balance (ABB), glucose and lactate content, lipid peroxidation (LPO) and antioxidant system (AOS), rheological properties of the blood were evaluated.Results. During AMI type 2 DM patients developed compensated metabolic lactic acidosis and oxidative distress that manifested in considerable activation of LPO and insufficient activity of the enzymatic component of AOS, blood viscosity grew, elasticity of red blood cells fell. Decreased local and global myocardial contractility was noted as well. During PCI in this category of patients, cardiac rhythm disorders developed in 47.4% of cases, 23.7% of which were life threatening, such as multifocal ventricular extra systole and ventricular fibrillation. Conclusion. Administration of a succinate-containing drug during performance of PCI provided correction of the lipid peroxidation processes and rheological properties of the blood in the population studied, facilitated improvement of left ventricle’s systolic and diastolic function, reduced the risk of reperfusion complications.https://www.reanimatology.com/rmt/article/view/1771myocardial infarctiondiabetes mellituslipid metabolismsuccinic acidreamberinsuccinatecontaining drugsreperfusion injury |
| spellingShingle | E. A. Kornienko Prophylaxis of Reperfusion Complications in Treatment of Acute Myocardial Infarction in Type 2 Diabetes Mellitus Patients Общая реаниматология myocardial infarction diabetes mellitus lipid metabolism succinic acid reamberin succinatecontaining drugs reperfusion injury |
| title | Prophylaxis of Reperfusion Complications in Treatment of Acute Myocardial Infarction in Type 2 Diabetes Mellitus Patients |
| title_full | Prophylaxis of Reperfusion Complications in Treatment of Acute Myocardial Infarction in Type 2 Diabetes Mellitus Patients |
| title_fullStr | Prophylaxis of Reperfusion Complications in Treatment of Acute Myocardial Infarction in Type 2 Diabetes Mellitus Patients |
| title_full_unstemmed | Prophylaxis of Reperfusion Complications in Treatment of Acute Myocardial Infarction in Type 2 Diabetes Mellitus Patients |
| title_short | Prophylaxis of Reperfusion Complications in Treatment of Acute Myocardial Infarction in Type 2 Diabetes Mellitus Patients |
| title_sort | prophylaxis of reperfusion complications in treatment of acute myocardial infarction in type 2 diabetes mellitus patients |
| topic | myocardial infarction diabetes mellitus lipid metabolism succinic acid reamberin succinatecontaining drugs reperfusion injury |
| url | https://www.reanimatology.com/rmt/article/view/1771 |
| work_keys_str_mv | AT eakornienko prophylaxisofreperfusioncomplicationsintreatmentofacutemyocardialinfarctionintype2diabetesmellituspatients |